Glia-to-neuron transfer of miRNAs via extracellular vesicles: a new mechanism underlying inflammation-induced synaptic alterations by Prada, Ilaria et al.
Vol.:(0123456789) 
Acta Neuropathologica 
https://doi.org/10.1007/s00401-017-1803-x
ORIGINAL PAPER
Glia‑to‑neuron transfer of miRNAs via extracellular vesicles: a new 
mechanism underlying inflammation‑induced synaptic alterations
Ilaria Prada1  · Martina Gabrielli1 · Elena Turola2 · Alessia Iorio1 · Giulia D’Arrigo3 · Roberta Parolisi4 · 
Mariacristina De Luca5 · Marco Pacifici5 · Mattia Bastoni6 · Marta Lombardi7 · Giuseppe Legname3 · Dan Cojoc8 · 
Annalisa Buffo4 · Roberto Furlan6 · Francesca Peruzzi5 · Claudia Verderio1,7
Received: 4 September 2017 / Revised: 18 December 2017 / Accepted: 28 December 2017 
© The Author(s) 2018. This article is an open access publication
Abstract
Recent evidence indicates synaptic dysfunction as an early mechanism affected in neuroinflammatory diseases, such as 
multiple sclerosis, which are characterized by chronic microglia activation. However, the mode(s) of action of reactive 
microglia in causing synaptic defects are not fully understood. In this study, we show that inflammatory microglia produce 
extracellular vesicles (EVs) which are enriched in a set of miRNAs that regulate the expression of key synaptic proteins. 
Among them, miR-146a-5p, a microglia-specific miRNA not present in hippocampal neurons, controls the expression of 
presynaptic synaptotagmin1 (Syt1) and postsynaptic neuroligin1 (Nlg1), an adhesion protein which play a crucial role in 
dendritic spine formation and synaptic stability. Using a Renilla-based sensor, we provide formal proof that inflammatory 
EVs transfer their miR-146a-5p cargo to neuron. By western blot and immunofluorescence analysis we show that vesicular 
miR-146a-5p suppresses Syt1 and Nlg1 expression in receiving neurons. Microglia-to-neuron miR-146a-5p transfer and 
Syt1 and Nlg1 downregulation do not occur when EV–neuron contact is inhibited by cloaking vesicular phosphatidylserine 
residues and when neurons are exposed to EVs either depleted of miR-146a-5p, produced by pro-regenerative microglia, or 
storing inactive miR-146a-5p, produced by cells transfected with an anti-miR-146a-5p. Morphological analysis reveals that 
prolonged exposure to inflammatory EVs leads to significant decrease in dendritic spine density in hippocampal neurons 
in vivo and in primary culture, which is rescued in vitro by transfection of a miR-insensitive Nlg1 form. Dendritic spine loss 
is accompanied by a decrease in the density and strength of excitatory synapses, as indicated by reduced mEPSC frequency 
and amplitude. These findings link inflammatory microglia and enhanced EV production to loss of excitatory synapses, 
uncovering a previously unrecognized role for microglia-enriched miRNAs, released in association to EVs, in silencing of 
key synaptic genes.
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Introduction
Microglia, the resident immune cells of the brain, are fun-
damental to brain development and function [53], and have 
a recognized role in brain inflammation. Besides partici-
pating in information processing at the level of synapses, 
microglia are involved in complex brain functions, such as 
learning-induced synaptic plasticity, memory and cognition 
[49, 54, 55], and mouse behaviour [21, 44]. It is generally 
assumed that the broad activity of microglia relies on their 
capability to secrete soluble molecules, which not only 
mediate homeostatic synaptic plasticity in response to neu-
ronal inputs [42, 54], but also cause synaptic damage upon 
early microglia responses [17]. Among microglia-derived 
soluble factors known to affect synaptic function and alter-
ing neuron excitability, inflammatory cytokines, i.e. TNF-α 
and IL-1β, play a critical role in chronic neuroinflammatory 
disorders, by modulating the expression and/or properties 
of synaptic channels [12, 55, 65, 79, 81], and regulating 
the expression of molecules critical for synaptic plasticity, 
including CREB or cofilin [73]. Recent studies have revealed 
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that microglia can also regulate synapses through contact-
dependent mechanisms, including engulfment of synaptic 
elements [74, 80, 82]. However, the mechanism(s) leading to 
microglia-mediated synapse loss during brain inflammation 
remain unknown and whether reactive microglia may disrupt 
synaptic structure and function by silencing synaptic genes 
has never been explored.
MicroRNAs (miRNAs) are small non-coding RNAs of 
approximately 22 nucleotides in length, known to regulate 
post-translational transcription [25]. The highest expres-
sion of tissue-specific miRNAs has been found in the brain 
[4, 67, 69], and a specific set of miRNAs are localized to 
dendrites, where local translation may affect dendritic spine 
morphology [68] and participate in adult neural plasticity 
[30, 46]. MiRNAs are abundant and play a key role also in 
the immune system [9, 83]. Once released by cells, miRNAs 
circulating in body fluids are promising markers of specific 
diseases, serving a diagnostic purpose particularly in brain 
“fluid biopsies” [36, 77]. Their suitability in diagnostics is 
also due to the remarkable stability of miRNAs to exogenous 
ribonucleases, being either associated to miRNA-processing 
molecules such as argonaute2 [2, 47], or packaged into EVs, 
which protect them from degradation [56].
EVs are membranous vesicles that bud from the plasma 
membrane (MVs/ectosomes) or result from exocytosis of 
multivesicular bodies (exosomes). Carrying a defined but 
mixed cargo of biomolecules, such as RNAs, proteins and 
lipids, EVs possess unique biological activities with the abil-
ity to modulate profoundly the molecular configuration and 
behaviour of target cells [15]. Recent evidence indicates that 
microglia and other glial cells can communicate with neu-
rons through secretion of EVs [10, 43]. Microglia-derived 
EVs carry bioactive lipids, including endocannabinoids, 
which acutely impact neuronal firing rate [1, 29, 62]. Under 
pathological conditions, microglial EVs become vehicle 
of pathogenic proteins, e.g. the pro-inflammatory cytokine 
IL-1β [6], pathogenic Aβ and tau protein [3, 38] which are 
toxic to recipient neurons. EVs released by astrocytes con-
tain and transfer miRNAs to metastatic tumour cells, thus 
promoting brain metastasis [86]. Importantly, the miRNA 
cargo of EVs produced by astrocytes and oligodendrocytes 
may also regulate the expression of neuronal genes [18, 27, 
45]. Despite these advances, no formal proof for glia-to-
neuron transfer of miRNAs has been provided, and whether 
vesicular miRNA is essential to alter gene expression in 
recipient neurons remains to be established.
In this study, we investigated whether inflammatory 
microglia transfer bioactive miRNAs to neurons through 
secretion of EVs. By exposing donor microglia to pro-
inflammatory or pro-regenerative stimuli, we upregulated 
and downregulated, respectively, the level of miR-146a-5p 
in EVs and found that miR-146-5p-enriched EVs fuse with/
and transfer their miR-146a-5p cargo to neurons, resulting 
in downregulation of miR-146a-5p synaptic targets with a 
considerable impact on synapse stability.
Materials and methods
Brain cell cultures
Mixed glial cell cultures, containing both astrocytes and 
microglia, were established from both male and female rat 
Sprague–Dawley pups (P2) (Charles River, Lecco, Italy) 
and maintained as previously described [59]. To obtain 
pure microglia (> 98%), cells were harvested from 10- to 
14-day in vitro (DIV) cultures by orbital shaking for 30 min 
at 1300 r.p.m. and re-plated on poly-dl-ornithine-coated tis-
sue culture dishes. The purity of the microglia preparation 
was identified by live staining with 0.01 mg/ml Isolectin-
B4 Alexa 488-conjugated (Molecular Probes, Life Tech-
nologies Ltd., Paisley, UK) for 5 min at 37 °C, followed by 
staining with rabbit anti-GFAP or anti-NG2 and DAPI of 
fixed cells [4% paraformaldehyde–4% sucrose (w/v)] (Fig. 
S1). These cells express a partial molecular signature char-
acteristic of acute ex vivo adult microglia [23]. Microglia 
were stimulated with a cocktail of Th1 cytokines (20 ng/ml 
IL-1β, 20 ng/ml TNF-α and 25 ng/ml IFN-γ), with 20 ng/
ml IL-4 or 2 μM aggregated Aβ 1–42 for 24 h. Aβ 1–42 
(Anaspec, Fremont, CA, USA) was dissolved at a concentra-
tion of 2 mM in DMSO, kept at − 80° and diluted in glial 
medium [38]. Successful polarization towards inflammatory 
or pro-regenerative phenotype under these conditions was 
confirmed (data not shown), according to previous studies 
[11, 78, 84].
Astrocytes were exposed to LPS 0.4 μg/ml for 6 h to 
induce an inflammatory response. Primary neuronal cultures 
were obtained from the hippocampi of 18-day-old foetal 
Sprague–Dawley rats (Charles River, Lecco, Italy). Briefly, 
dissociated cells were plated onto poly-l-lysine (Sigma 
Aldrich, Saint Louis, MO) treated coverslips/dishes and 
maintained in Neurobasal medium supplemented with 2% 
B27 supplement (Life Technologies, Carlsbad CA, USA). In 
a set of experiment neurons were treated with heparitinase I 
(0.5 mU/ml) for 30 min at 37 °C before treatment with EVs.
Glia–neuron cocultures
To maintain neurons in co-culture with inflammatory micro-
glia/astrocytes, neurons were grown on glass coverslips 
while microglia/astrocytes were plated separately on wells 
and treated with Th1 cytokines/LPS for 24 h. At the end 
of the incubation, cytokines/LPS were removed and neu-
rons were introduced on top of glial cells, suspended over 
glial cells but not in contact with them, as established by 
Bartlett and Banker [5]. Every 24 h for a period of 72 h the 
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coverslips with neurons were moved to a new well contain-
ing cytokine-primed microglia or LPS-primed astrocytes in 
order to avoid a change in the activation state of inflam-
matory cells. All the experimental procedures to establish 
primary cultures followed the guidelines established by the 
European legislation (Directive 2010/63/EU), and the Italian 
Legislation (LD no. 26/2014).
Isolation, labelling and treatment of EVs
Cells were thoroughly washed and stimulated with 1 mM 
ATP for 30 min to favour MV secretion or for 1 h to induce 
accumulation of both MVs and exosomes in Krebs–Ringer’s 
HEPES solution (KRH) (125 mM NaCl, 5 mM KCl, 1.2 mM 
 MgSO4, 1.2 mM  KH2PO, 2 mM  CaCl2, 6 mM d-glucose, 
and 25 mM HEPES/NaOH, pH 7.4). Conditioned KRH was 
collected and pre-cleared from cells and debris at 300×g for 
10 min (twice). MVs were then pelleted from the superna-
tant by a centrifugation step at 10,000×g for 30 min, while 
exosomes were subsequently isolated from the supernatant 
at 100,000×g for 1 h. MVs- and exosome-enriched pellets 
were either lysed for RNA isolation using Direct-zol™ RNA 
MiniPrep kit (Zymo Research, Irvine CA, USA) or imme-
diately re-suspended in neuronal medium. Unless other-
wise specified, 1.7 × 105 neurons were incubated with MVs 
derived from 2 × 106 M1-/M2-microglia (1 × 108 particle/
ml) or 6 × 106 astrocytes every 24 h for 72 h to keep EV 
concentration chronically elevated. In a set of experiments, 
MVs were treated with annexin-V (0.84 μg/ml) to cloak PS 
residues, before delivery to neurons by optical tweezers. For 
protection assay, MVs/exosomes have been incubated with 
20 mU/ml RNase I and 1% TritonX-100 for 20 min at room 
temperature, as described previously [72].
EV quantification
Tunable Resistive Pulse Sensing (TRPS) technique, by Izon 
qNano instrument (Izon, Christchurch, New Zealand), was 
used to measure the size distribution and concentration of 
particles in isolated MV- and exosome-enriched fractions. 
A reagent kit from Izon (Izon EV reagent kit) was used for 
both pre-treating the pore and suspending EVs in order to 
prevent EV binding to the pore or spontaneous EV aggrega-
tion. MVs or exosomes produced by 1 × 106 microglia in 1 h 
were re-suspended in a volume of 100 μl. NP300 nanopore 
(150–600 nm diameter range; Izon) was used for MV sam-
ple analysis, while NP150 nanopore (85–300 nm diameter 
range; Izon) was used for exosome sample analysis. In each 
experiment, the same applied voltage, pressure and pore 
stretch values were set for all MV/exosome sample record-
ings and relative calibration. CPC200 calibration particles 
(carboxylated polystyrene particles, supplied by Izon and 
diluted following manufacturer’s instructions) were used as 
standards. They were measured immediately before or after 
the experimental samples under identical conditions. Data 
acquisition and analysis were performed using Izon Control 
Suite software (version V3.2). MV and exosome concentra-
tion values were normalized on protein concentration rela-
tive to donor cell sample, determined through bicinchoninic 
acid assay (BCA, Fisher Scientific, Waltham MA, USA).
Exiqon miRNA profiling and data analysis
Total RNA was extracted from microglia, MVs and 
exosomes using the Direct-zol™ RNA MiniPrep kit (Zymo 
Research, Irvine CA, USA). For miRNA profiling, 25 ng of 
RNA from each sample was subjected to retro-transcription 
using the Universal cDNA synthesis kit (Exiqon, Woburn, 
MA), followed by qRT-PCR (SYBR green Master Mix, 
Exiqon). MiRNA arrays (V2.0 version) were carried out 
on a Roche Light Cycler 480 Real Time PCR system using 
the mouse/rat panel I. Raw data were converted into cycle 
threshold (Ct) measurements by the Roche Light Cycler 
system software (Version 1.5; Roche). Quantification using 
2nd derivative maximum was further calculated with Roche 
Light Cycler 480 software. Q-PCR data were further ana-
lysed in GenEx Professional 5 software (MultiD Analyses 
AB, Goteborg, Sweden). After inter-plate calibration, a 
cut-off of 38 was applied and the amount of target miR-
NAs was normalized relative to the amount of RNU1A1 
and RNU5G, as determined by geNorm application incor-
porated into GenEx. Relative quantification was calculated 
as fold-change of miRNA expression in the experimental 
groups according to the formula 2−ΔΔCt, as previously [24, 
41, 51, 52].
Quantitative real‑time PCR
q-PCR for detection of mature miR-146a-5p, miR-181a and 
miR-223 microRNAs was performed using the miRCURY 
LNA™ Universal RT microRNA PCR system (Exiqon) 
according to the manufacturer’s instructions. The assays were 
run on a QuantStudio™ 5 (ThermoFisher Scientific, Waltham 
MA, USA) real-time PCR system. Relative quantification was 
calculated using the QuantStudio™ 5 design and analysis 
software (Applied Biosystems, Foster City CA, USA) (based 
on the 2nd derivative maximum). In the RNase I protection 
assay, where the endogenous control (RNU1A1) is degraded 
as well as the miRNAs of interest as consequence of RNase 
treatment, the relative abundance of miRNAs was calculated 
from the expression 2^ − (Ctexperimental − Ctcontrol), expressed 
in percentage [72]. The miRNA contents of human CSF EVs 
and of cultured neurons were analysed independently of any 
other sample, therefore the relative abundance was expressed 
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as dCt: Cttarget − Ctreference, where RNU1A1 is considered as 
the endogenous control.
Exiqon primers Cat. number
rno-miR-181a Ref# 206081
rno-miR-146a-5p Ref# 204688
mmu-miR-223 Ref# 205986
mmu-has-RNU1A1 Ref# EX203909
CSF samples
Human CSF has been obtained for diagnostic purposes from 
subjects with multiple sclerosis according to revised McDon-
ald criteria [58] attending the MS Center at San Raffaele 
Hospital (Milan, Italy). Total EVs were isolated from sam-
ples smaller than 1 ml of CSF pooled together from ten MS 
patients. MiRNAs were isolated and q-PCR was performed 
as described above. This research project was approved by the 
ethical committee of San Raffaele Scientific Institute, and all 
subjects gave written informed consent.
Dual luciferase assay
The mature sequences of miR-146a-5p and cel-miR-39 were 
cloned into BlockIt (Invitrogen) following the manufacturer’s 
protocol, as described previously [64]. For the cloning of the 
perfect match sequence into pSiCheck-2 vector (Promega, 
Madison, WI, USA), the PCR primers were based on the 
mature sequence of miR-146a-5p/cel-miR-39 but in the anti-
sense orientation.
Neurons were transfected with a total amount of 0.3 μg/
well of DNA (miR-146a-5p pSiCheck; cel-miR-39 pSiCheck) 
using Lipofectamine 2000™ (Invitrogen), at DIV 7–8, when 
higher transfection efficiency is achieved compared to mature 
neurons. After 24 h 1.7 × 105 transfected neurons were incu-
bated overnight with glial MVs secreted by 1 × 106 micro-
glia (2.3 × 107 particle count/ml) or 3 × 106 astrocytes, which 
release less EVs compared to microglia [1] in 30–60 min. Sam-
ples were harvested 48 h post-transfection and subjected to the 
dual luciferase assay system (Promega). Donor astrocytes were 
transfected with anti-miR-146a-5p (30 nM miRCURY LNA; 
Exiqon) using Lipofectamine 2000 before EV isolation. To 
verify miR-146a-5p inactivation astrocytes were co-transfected 
with miR-146a-5p pSiCheck and anti-miR-146a-5p. In a set of 
experiments EVs were treated with annexin-V (0.84 μg/ml) for 
30 min at room temperature, before being applied to neurons.
Confocal analysis of Syt1 immunoreactivity
Hippocampal neurons were transfected at DIV 7–8 with 
eGFP or miR-146a-5p (BlockIt) (1 μg of DNA/coverslip) 
using Lipofectamine 2000. After 24 h 1.7 × 105 neurons 
were incubated with MVs derived from 6 × 106 astrocytes 
for 48 h, fixed with 4% paraformaldehyde–4% sucrose 
(w/v) and stained with rabbit anti-Syt1 and goat anti-GFP 
FITC conjugated, followed by Alexa-555 conjugated sec-
ondary antibodies (1:200, Alexa-Invitrogen, San Diego, 
CA). Images were acquired using a Leica SPE confocal 
microscope equipped with a 63 ×  /1.30 NA oil objec-
tive (Leica Microsystems, Solms, Germany). Acquisi-
tion parameters (i.e. laser power, gain and offset) were 
kept constant among different experimental settings. Syt1 
staining was quantified by the ImageJ software (http ://
rsb.info .nih.gov/ij/) on Z-stacks, in order to measure the 
signal coming from the total volume of the cells. ROIs 
were drawn on the somatodendritic compartment and the 
fluorescence intensity for Syt1 was measured with the his-
togram function of the software after definition of an arbi-
trary, but homogeneous threshold. The same was done for 
the eGFP signal, which was saturated purposely, giving a 
measure of the total number of pixel present in the volume. 
Syt1 expression has been expressed as the fluorescence 
intensity normalized for the cell body volume.
Western blotting
Neurons treated with EVs for 72 h were lysed with a buffer 
containing 1% sodium dodecyl sulfate (SDS), 10 mM 
HEPES, 2 mM EDTA pH 7.4. A modified version of the 
Laemmli buffer (20 mM Tris pH 6.8, 2 mM EDTA, 2% 
SDS, 10% glycerol, 2% β-mercaptoethanol, 0.01% bromo-
phenol blue) was then added to a final 1× concentration 
and proteins were separated by gel electrophoresis, blotted 
on nitrocellulose membrane filters and probed using the 
antibodies reported in the table. Photographic develop-
ment was by chemiluminescence (ECL, GE Healthcare) 
according to the manufacturer’s instructions. Western blot 
bands were quantified by ImageJ software.
Antibody Host Supplier WB dilution IF dilution
Anti-β-III 
tubulin
Mouse Promega 
(Madison, 
WI, USA)
1:4000
Anti-Bassoon Guinea pig Synaptic Sys-
tems (Goet-
tingen, 
Germany)
1:500
Anti-GAPDH Rabbit Synaptic Sys-
tems (Goet-
tingen, 
Germany)
1:2000
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Antibody Host Supplier WB dilution IF dilution
Anti-GFAP Rabbit Synaptic Sys-
tems (Goet-
tingen, 
Germany)
1:300
Anti-GFP-
FITC
Goat Novus 
Biologicals 
(Littleton, 
CO, USA)
1:300
Anti-MAP2 Mouse Sigma 
Aldrich 
(Saint 
Louis, MO, 
USA)
1:1000
Anti-NG2 Rabbit Millipore 
(Burling-
ton, MA, 
USA)
1:100
Anti-Nlg1 Mouse Synaptic Sys-
tems (Goet-
tingen, 
Germany)
1:1000
Anti-NR2B Mouse Synaptic Sys-
tems (Goet-
tingen, 
Germany)
1:1000
Anti-PSD95 Mouse NeuroMab 
(Davis, CA)
1:5000
Anti Shank2 Rabbit Synaptic Sys-
tems (Goet-
tingen, 
Germany)
1:500
Anti-SNAP25 Mouse SMI81 
Sternberger 
Monoclo-
nals
1:10000
Anti-Syt1 Rabbit Synaptic Sys-
tems (Goet-
tingen, 
Germany)
1:1000 1:200
Cell viability assays
The assay was performed as previously described [38]. 
Neuron viability was analysed by simultaneous fluores-
cence staining of viable and dead cells with calcein-AM 
(0.5 mg/ml, Invitrogen, Life Technologies Ltd.), propidium 
iodide (1 mg/ml, Molecular Probes, Life Technologies Ltd., 
Paisley, UK) and Hoechst (8.1 mM, Molecular Probes, Life 
Technologies Ltd.). Incubation was performed for 20 min in 
neuronal medium at 37 °C and 5%  CO2. Calcein-AM emits 
green fluorescence signal in viable cells, while PI reaches 
nuclei of only dead cells emitting red fluorescence. Fluores-
cence images were acquired by Leica DMI 4000B micro-
scope (Leica Microsystems GmbH, Wetzlar, Germany), 
equipped with DIC microscopy. The percentage of neuronal 
death was calculated as the ratio of  PI+/calcein+-dead cells 
to the total number of Hoechst-stained neurons in at least 
15 fields/condition.
RFP‑transfection and dendritic spine analysis
1.7 × 105 neurons were transfected at DIV14 with a RFP or 
an Nlg1-HA expressing vector [pCAG-NL1(−)], gift from 
Peter Scheiffele (Addgene plasmid #15260) using Lipo-
fectamine 2000 (0.5 μg of plasmid). At this developmen-
tal stage the efficiency of transfection is quite low (~ 5%). 
Neurons were then incubated with MVs for 72 h, fixed and 
stained with guinea pig anti-Bassoon and rabbit anti-Shank2. 
Secondary antibodies were conjugated with Alexa-488 and 
Alexa-633 (1:200, Alexa-Invitrogen, San Diego, CA). Neu-
rons were imaged with a 63× objective using an Axiovert 
200 M (Zeiss) confocal system equipped with a spinning 
disk (UltraVIEW acquisition system, Perkin Elmer) keep-
ing acquisition parameters constant. Focal planes were 
stacked together in a projection, and RFP-positive spines 
were counted on 20–40 μm segments of secondary den-
drites. The spine density was calculated as number of spines 
per 10 μm of dendrite. The abundance of different types 
of spines (mushroom, thin and stubby) was analysed using 
the ImageJ software (http ://imag ej.nih.gov/ij/). Spines were 
classified in categories based on morphological parameters: 
spine head diameter (H), spine length (L) and spine neck 
width (N), according to NeuronStudio software criteria: 
mushroom spines: H/N > 1.1 μm and H > 0.35 μm; thin 
spines: H/N > 1.1 μm and H < 0.35 μm or H/N < 1.1 μm 
and L/H  >  2.5  μm; stubby spines: H/N  <  1.1  μm and 
L/H < 2.5 μm. Approximately 60 spines per field were meas-
ured in at least 15 dendrites per independent experiments.
The percentage of synapses with pre- and post-synaptic 
terminals was measured in a single confocal plane as fol-
lows: Bassoon and Shank2 double-positive puncta were 
revealed by generating a Bassoon/Shank2 double-positive 
image using the ‘and’ option of ‘image calculator’ function. 
A fixed threshold was then set in the double-positive image 
and number of double-positive puncta was quantified using 
the ‘analyze particle’ function and normalized to the total 
number of Shank2-positive puncta to obtain the fraction of 
Shank2-positive presynaptic terminals.
Electrophysiological recordings
Non-transfected hippocampal neurons were incubated with 
MVs for 72 h. Whole-cell voltage clamp recordings were 
then performed using a MultiClamp 700A amplifier (Molecu-
lar Devices) coupled to a pCLAMP 10 Software (Molecular 
Devices), and using an inverted Axiovert 200 microscope 
(Zeiss). MEPSC were recorded from DIV 13–15 neurons 
using external control solution KRH, in the presence of 1 µM 
TTX. Experiments were performed at room temperature 
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(20–25 °C), setting the holding potential at − 70 mV and 
using the following internal solution: 130 mM CsGluc, 8 mM 
CsCl, 2 mM NaCl, 10 mM HEPES, 4 mM EGTA, 4 mM 
MgATP, 0,3 mM Tris-GTP (pH 7.3, adjusted with CsOH). 
Traces were sampled at 10 kHz and filtered at 2 kHz. Series 
resistance was monitored during recording. mEPSC were 
detected using Clampfit software (Molecular Devices) set-
ting a threshold of 5 pA. The mean mEPSC frequency for 
CTRL neurons was 1.537 ± 0.356 Hz (mean ± SE), their 
mean amplitude was 25.445 ± 1.503 pA (mean ± SE).
In vivo EVs delivery and dendritic spine analysis
In vivo experiments were performed on 4-month-old 
C57BL6 male mice (n = 3/condition). Surgery and perfu-
sions were carried out under deep general anAesthesia (keta-
mine, 100 mg/kg; Ketavet, Bayern, Leverkusen, Germany; 
xylazine, 5 mg/kg; Rompun, Bayer, Leverkusen, Germany). 
The experimental plan was conducted in accordance with 
the European directive (2010/63/EU) and the Italian Law 
for Care and Use of Experimental Animals (DL116/92). It 
was also approved by the Italian Ministry of Health and the 
Bioethical Committee of the University of Turin. Osmotic 
minipumps (Alzet osmotic pumps 1007D) were implanted 
unilaterally in CA1 (anteroposterior: 1.8 mm relative to 
bregma; mediolateral: +1 mm; dorsoventral: 1.5 mm rela-
tive to the dura) where they infused rat M1-EVs (1.5 µg/
µl, diluted in sterile saline), M2-EVs or saline (vehicle) at 
0.5 µl/h for 4 days. The contralateral side was used as addi-
tional control (intact). The brains were removed and stained 
by modified Golgi–Cox method as described in [85]. Coro-
nal sections of 100 µm thickness from the dorsal hippocam-
pus were obtained using a vibratome (Leica Microsystems 
GmbH). Slices were mounted on gelatin-coated microscope 
slides, stained, dehydrated and mounted with a xylene-based 
medium. Images of Golgi sections were acquired through 
Video-Confocal Microscope (VICO, Nikon Instruments), 
with a 60× oil immersion lens. Spine density was quanti-
fied on the secondary branches of neurons located in the 
CA1 of the dorsal hippocampus, by ImageJ software. At the 
site of minipump implantation dendrites were analysed at 
distances ranging from 50 to 400 μm from the cannula track, 
to exclude artefacts due to direct neuron damage.
Optical tweezers
An IR laser beam (1064 nm, CW) for trapping was coupled into 
the optical path of an inverted microscope (Axiovert 200 M, 
Zeiss) through the right port of the microscope. The trapping 
beam was directed to the microscope lens (Zeiss 63X, NA 1.4) 
by the corresponding port mirror (100%) and the tube lens. Opti-
cal trapping and manipulation of EVs was performed following 
the approach previously described [59]. Immediately before 
recording, MVs produced by glial cells pre-loaded with cal-
cein/AM (20 nM for 45 min) were added to neurons plated on 
glass coverslips and maintained in 400 µl of neuronal medium 
in a temperature controlled recording chamber at 37 °C. As 
soon as a calcein-positive MV appeared in the recording field, 
it was trapped and positioned on a selected neuron by moving 
the cell stage horizontally and the microscope lens axially. After 
about 30 s from contact, the laser was switched off to prove 
EV–neuron interaction. During the experiments neurons were 
live imaged with a spinning disk confocal microscope (Ultra-
VIEW acquisition system, Perkin Elmer Waltham, MA, USA) 
using a digital camera (High Sensitivity USB 3.0 CMOS Cam-
era 1280 × 1024 Global Shutter Monochrome Sensor, Thorlabs, 
Newton, NJ, USA) at a frame rate of 2 Hz.
Membrane fusion assay
In another set of experiments, MVs have been obtained from 
glial cells (1 × 106) preloaded with calcein-AM (0.5 mg/ml) 
for 20 min in complete medium at 37 °C and 5%  CO2. Calcein-
AM loaded EVs were then labelled with the self-quenching 
lipophilic dye octadecyl rhodamine B chloride (R18, 0.2 µM) 
(Life Technologies, Carlsbad CA, USA) for 30  min at 
room temperature, washed twice in KRH and re-pelleted at 
10,000×g before being added to 1.7 × 105 neurons and live 
imaged. Fluorescence of calcein-R18 doubled labelled MVs 
approaching the surface of neurons in the observation field was 
monitored at 510–590 nm emission for 5 min. Images were 
acquired at 2 Hz. Calcein/R18 mean fluorescence intensity 
was measured using ImageJ software at ROIs selected around 
MVs in sequence of images to obtain temporal analysis. Fluo-
rescence changes were expressed as F–F0, where F0 is the 
fluorescence measured when the MV enters the focal plane.
Statistical analysis
All data are presented as mean ± SE from the indicated num-
ber of independent experiments. Statistical analysis was per-
formed using SigmaPlot 12.0 (Jandel Scientific, San Jose, CA, 
USA) software. After testing data for normal distribution, the 
appropriate statistical test has been used (see figure legends). 
Differences were considered significant when P was < 0.05, 
P < 0.01 and P < 0.001 and they are indicated by one, two or 
three asterisks, respectively.
Results
EVs contain a selected set of miRNAs of parental 
microglia
Newborn rat microglia were maintained in culture 
medium enriched with inflammatory (Th1 cytokines), 
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degenerative (amyloidogenic peptide Aβ 1–42) or pro-
regenerative (IL-4) stimuli. Polarized cells were then 
exposed to ATP for 1 h to promote release of MVs but 
also accumulation of exosomes. MVs and exosomes 
were isolated by differential centrifugation as described 
[29]. Our previous evidence indicates that EVs isolated 
under short ATP stimulation are negative for apoptotic 
markers and are not contaminated by intracellular orga-
nelles derived from damaged cells, as indicated by elec-
tron microscopy [6, 78] and western blot analysis [29]. 
Quantification by tunable resistive pulse sensing (TRPS) 
revealed that unstimulated microglia (1  ×  106  cells) 
showed secretion rate of ~ 3.5 × 107 MVs (mean diam-
eter = 182.82 ± 3.35 nm) and ~ 1 × 108 exosomes (mean 
diameter = 92 ± 5.28 nm) per hour. Pro-inflammatory 
and pro-regenerative microglia produce more MVs com-
pared to unstimulated cells, with no significant changes 
in exosome production (Fig. 1a).
MiRNA profiling in total RNA from MVs, exosomes 
and parental cells using a comprehensive mouse and rat 
miRNA panel and RNU1A1 and RNU5G as normalizers, 
revealed 245 miRNAs in at least two out of the three sam-
ples, which were then selected for further analysis. We 
found a total of 78 and 71 miRNAs, respectively, in MVs 
and exosomes produced by non-stimulated (NS) micro-
glia, of which 21 were unique in MVs and 14 unique in 
exosomes (Fig. 1b), with a strong overlap between the 
two EV populations (57 common miRNAs). This overlap 
may derive in part from the centrifugation procedure used 
to collect EVs, which does not allow a precise separa-
tion of the two EV populations. Compared to parental 
microglia, EVs contained a selection of miRNAs and few 
vesicle-specific miRNAs, not detectable in donor cells. 
Q-PCR analysis showed that some miRNAs were sev-
eral folds more represented in MVs and exosomes than in 
donor cells, while others were low abundant in MVs and 
exosomes than in cells (Fig. 1c, Fig. S2). This suggested 
that vesicular miRNAs are not the result of random sam-
pling. A similar sorting mechanism appeared to regulate 
miRNA traffic to EVs produced by reactive microglia 
(Fig. S3a–c). Relative abundance of EV miRNAs versus 
cellular miRNAs showed that more than 50% of miRNAs 
were upregulated (fold change > 2) in MVs and exosomes 
produced by NS microglia (Fig. 1d).
Identification of miRNAs altered in EVs produced 
by pro‑inflammatory versus pro‑regenerative 
microglia
We next analysed miRNAs differentially expressed in EVs 
(MVs or exosomes) released from microglia stimulated with 
inflammatory cytokines (M1-EVs), Aβ 1–42 (Aβ-EVs) or 
with IL-4 (M2-EVs). Differential expression analysis of 
M1-EVs versus M2-EVs revealed 21 miRNAs, among which 
11 were upregulated and 10 downregulated in M1-EVs 
(Fig. 1e; Table 1). Similarly, 12 upregulated and 11 down-
regulated miRNAs were differentially expressed between 
Aβ-EVs and M2-EVs (Fig. 1e; Table 2). We then searched 
for miRNAs upregulated in both M1-EVs and Aβ-EVs. We 
found three miRNAs that have validated dendritic targets, 
namely rno-miR-146a-5p, rno-miR-181a and rno-miR-223 
(Fig. 1e; Tables 1, 2). MiR-146a-5p targets the postsynaptic 
cell-adhesion molecule neuroligin1 (Nlg1), the dendritic 
protein MAP1A and the synaptic vesicle protein synaptotag-
min1 (Syt1) [39]; miR-181a targets the AMPA-selective glu-
tamate receptor 2 (GluR2) [66]; while miR-223 targets both 
GluR2 and the NMDA glutamate receptor GluN2B [33]. All 
the synaptic targets of miR-146a-5p, miR-181a and miR-223 
are conserved between mouse and rat and Syt1 is a con-
served target also in human, as documented by Saba and 
coworkers [66] and the miRNA databases TargetScan v 7.1 
and microRNA.org. Q-PCR analysis confirmed upregulation 
of miR-146a-5p, miR-181a and miR-223 in EVs released 
from inflammatory microglia, especially in shed MVs, com-
pared to pro-regenerative cells (Fig. 2a). As expected for 
miRNAs packaged into a membrane bound compartment, 
they were protected from degradation by RNase I unless 
a detergent was added to disrupt the membrane of EVs 
(Fig. 2b).  
miR‑146a‑5p, miR‑181a and miR‑223 are present 
in EVs of patients with multiple sclerosis
Previous evidence indicates that miR-146a-5p, miR-181a 
and miR-223 are dysregulated in patients affected by neuro-
inflammatory [36] and neurodegenerative diseases [22, 37, 
60], that are characterized by high production of myeloid 
EVs [38, 78]. In particular, consolidated evidence describes 
miR-146a-5p upregulation both at MS lesions [40] and in 
CSF from patients with Alzheimer’s diseases [32, 61]. To 
validate the presence of the three miRNAs in EVs produced 
by reactive microglia in vivo, we isolated a mixed population 
of EVs (MVs and exosomes) from a pool of CSF collected 
from 10 patients affected by multiple sclerosis (MS). Q-PCR 
analysis confirmed the presence of miR-146a-5p, miR-181a 
and miR-223 in the EVs isolated from CSF, where EVs of 
myeloid origin accounts for ~ 65% of total EVs detectable 
by flow cytometry [38] (Fig. 2c).
miR‑146a‑5p expression in astrocyte‑derived EVs 
but not in hippocampal neurons in vitro
Among the three miRNAs upregulated in EVs produced 
by inflammatory microglia, miR-146a-5p is a microglia-
enriched miRNA, detectable at lesser extend in astrocytes, 
and it prevents the expression of neuronal genes in neuron 
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Fig. 1  Analysis of miRNAs in EVs released from microglia. a Size 
profile of MVs and exosomes pelleted from 1 × 106 NS microglia, re-
suspended in 100 μl of 0.1 µm-filtered PBS and analysed using TRPS 
(left). Histograms show production of MVs and exosomes from 
microglia polarized with different agents during 1 h stimulation with 
ATP. Data are normalized to unstimulated condition (MVs, one-way 
ANOVA P ≤ 0.001; Holm–Sidak test versus control; exosomes: one-
way ANOVA P  =  0.501). b Venn diagram of the numerical values 
for common and unique miRNAs present in MVs (yellow), exosomes 
(green) and parental microglia under resting condition (blue). c Heat 
map of ∆Ct of miRNAs expressed in MVs, exosomes and unstimu-
lated cells. Red indicates low expression and green indicates high 
expression. d Pie charts depict the percentage of miRNAs that are 
upregulated (red), downregulated (green) and unchanged (grey) in 
MVs or exosomes versus unstimulated microglia. e Venn diagram of 
EV miRNAs differentially expressed in M1-EVs and Aβ-EVs versus 
M2-EVs
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progenitors [39]. Thus miR-146a-5p appeared as an ideal 
candidate to investigate possible glia-to-neuron shuttling 
of miRNAs through EVs. Q-PCR analysis confirmed that 
miR-146a-5p is present in cultured astrocytes and MVs 
thereof, more abundantly upon activation with LPS (Fig. 2e), 
although astrocytes express less miR-146a-5p compared to 
LPS-treated microglia (fold change microglia versus astro-
cytes: 73.96 ± 5.67). Conversely, miR-146a-5p was undetect-
able in cultured hippocampal neurons unlike miR-181a and 
miR-223 (Fig. 2d). We next explored possible miR-146a-5p 
shuttling from EVs to neurons by dual luciferase assay using 
astrocyte-derived EVs in addition to microglial EVs, as astro-
cytes are more amenable of transfection than microglia, mak-
ing easier the manipulation of their miR-146a-5p expression.
EVs secreted from inflammatory glia transfer 
miR‑146a‑5p to neurons
Hippocampal neurons were transfected with a Renilla-
based miR-146a-5p reporter and exposed overnight to 
Table 1  List of miRNAs 
upregulated or downregulated 
in MVs (normal font) and 
exosomes (italic font) 
produced from inflammatory 
(M1) microglia versus pro-
regenerative (M2) cells
Normal font denotes MVs-associated miRNAs
Italic font denotes exosomes-associated miRNAs
Bold font denotes miRNAs upregulated in both M1-EVs vs M2-EVs (this Table) and Abeta-EVs vs 
M2-EVs (Table 2)
M1-EVs vs M2-EVs
miRNAs upregulated Fold change miRNAs downregulated Fold change
rno-miR-181a 2.34 rno-miR-490 0.26
rno-miR-30c 2.46 rno-miR-124 0.35
mmu-miR-223 2.85 rno-miR-134 0.42
rno-miR-146a 6.92 mmu-miR-297b-3p 0.45
mmu-let-7g 3.27 mmu-miR-669b 0.23
mmu-miR-15a 3.01 mmu-miR-676 0.36
rno-miR-125a-5p 2.14 rno-miR-150 0.36
rno-miR-146a 5.81 rno-miR-214 0.25
rno-miR-16 2.56 rno-miR-290 0.17
rno-miR-17-1-3p 2.79 rno-miR-582 0.16
rno-miR-219-5p 2.05
rno-miR-23a 12.38
Table 2  List of miRNAs 
upregulated or downregulated 
in MVs (normal font) and 
exosomes (italic font) produced 
from Aβ-treated microglia 
versus pro-regenerative cells
Normal font denotes MVs-associated miRNAs
Italic font denotes exosomes-associated miRNAs
Bold font denotes miRNAs upregulated in both Abeta-EVs vs M2-EVs (this Table) and M1-EVs vs 
M2-EVs (Table 1)
Aβ-EVs vs M2-EVs
miRNAs upregulated Fold change miRNAs downregulated Fold change
mmu-miR-223 32.33 mmu-miR-297b-3p 0.28
mmu-miR-345-3p 2.72 mmu-miR-351 0.34
mmu-miR-582-3p 3.85 mmu-miR-574-3p 0.48
mmu-miR-676 2.88 mmu-miR-669b 0.20
rno-miR-142-3p 5.40 mmu-miR-676 0.43
rno-miR-146a 22.70 rno-let-7c 0.37
rno-miR-181a 4.58 rno-let-7i 0.17
rno-miR-19b 3.06 rno-miR-290 0.45
rno-miR-20a 5.19 rno-miR-338 0.36
rno-miR-345-5p 17.09 rno-miR-490 0.32
rno-miR-34a 4.39 rno-miR-582 0.29
rno-miR-99a 4.13
rno-miR-146a 4.39
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EVs, either MVs or exosomes, derived from inflammatory 
astrocytes. The reporter carries Renilla gene fused to miR-
146a-5p complementary sequence and firefly luciferase 
gene as normalization control. MiR-146a-5p binding to its 
match sequence inhibits translation of Renilla mRNA and 
decreases Renilla light emission (miR-146a-5p pSiCheck) 
[64] (Fig. 2f). Overnight exposure to reactive EVs (r-MVs or 
r-exosomes), but not MVs derived from unstimulated astro-
cytes (MVs), caused a significant reduction in Renilla/firefly 
luciferase activity in EV-treated neurons compared to control 
Fig. 2  Glia-to-neuron shuttling of miR-146a-5p via MVs. a Histo-
grams show relative quantification of miR-146a-5p miR-181a and 
miR-223 in MVs and exosomes released from inflammatory (M1) 
versus pro-regenerative (M2) microglia. b RNase I protection of 
miR-146a-5p, miR-181a and miR-223 quantified by q-PCR in MVs 
and exosomes produced by M1 microglia. EVs were treated with or 
without RNase I and/or Triton X-100 (n  =  2). c Graph shows dCt 
values of miR-146a-5p, miR-181a and miR-223 in EVs derived from 
human CSF from 10 MS patients. d Graph shows dCt values of miR-
146a-5p (undetectable), miR-181a and miR-223 in cultured neurons. 
e Representative q-PCR showing increased miR-146a-5p expression 
in MVs and exosomes released from LPS-treated versus control astro-
cytes. f–j 7- to 8-day-old neurons were transfected with miR-146a-5p 
or cel-miR-39 reporter, incubated overnight with EVs, harvested and 
subjected to the dual luciferase assay system using a multiwell plate 
reader. f Schematic representation of the Renilla/firefly-based reporter 
for miR-146a-5p. g The histogram shows measures of Renilla/fire-
fly activity in control untreated neurons (ctr), neurons co-transfected 
with 0.7  μg/ml miR-146a-5p (miR), and neurons exposed overnight 
to MVs or exosomes derived from reactive astrocytes (r-MVs, r-exo) 
or unstimulated cells (MVs). Relative units represent ratio between 
Renilla values and luciferase internal control. (ANOVA P < 0.0001 
Holm–Sidak multi-comparison test: **P  <  0.01, ***P  <  0.001, 
n = 5). h Renilla/firefly luciferase assay in neurons exposed to MVs 
derived from astrocytes treated with anti-miR-146a-5p inhibitor (anti-
miR) or a non-targeting sequence (scrambled). ANOVA P  <  0.001 
Holm–Sidak multi-comparison test: **P  <  0.01, ***P  <  0.001, 
n  =  3. i Renilla/firefly luciferase assay in neurons exposed to MVs 
pretreated or not with annexin-V (Annexin V), to limit MV–neuron 
contact. Kruskal–Wallis P  <  0.001 Dunn’s multi-comparison test 
**P < 0.01, ***P < 0.001, n = 3. j Donor astrocytes were transfected 
cel-miR-39, MVs pelleted from the supernatant and exposed to neu-
rons transfected with a specific miR-39 reporter, before Renilla and 
luciferase detection. ANOVA P < 0.0001 Holm–Sidak multi-compar-
ison test: *P < 0.05 **P < 0.01, n = 3
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untreated neurons, indicating an increase in neuronal miR-
146a-5p levels (Fig. 2g). By contrast, MVs released from 
astrocytes transfected with anti-miR-146a-5p (30 nM miR-
CURY LNA) did not reduce activity (Fig. 2h). MiR-146a-5p 
inactivation in donor astrocytes was indicated by enhanced 
Renilla/firefly luciferase activity in astrocytes transfected 
with the reporter (normalized Renilla/firefly luciferase 
activity: anti-miR-146a-5p  =  1.971  ±  0.249, scram-
ble = 1.167 ± 0.169; Student’s t test, P = 0.037; n = 4) while 
spectrometric quantification of MVs, performed according 
to [6], excluded alterations in MV production in anti-miR-
146a-5p-treated astrocytes (Fluorescence intensity: con-
trols = 30.000 ± 2.061, anti-miR-146a-5p = 33.885 ± 2.091, 
scramble 29.353 ± 2.240). Finally, the EV–neuron adhe-
sion blocker annexin-V (0.84 μg/ml, see below Fig. 7b) 
prevented the Renilla/firefly activity reduction induced by 
MVs (Fig. 2i). MVs or exosomes secreted from inflam-
matory microglia caused a similar reduction in Renilla/
firefly luciferase activity (normalized Renilla/Firefly lucif-
erase activity: control = 1 ± 0.06; MVs = 0.62 ± 0.04; 
exosomes  =  0.61  ±  0.04; n  =  4, ANOVA P  ≤  0.001; 
Holm–Sidak multi-comparison test: MVs vs. control 
P < 0.0001). Taken together these data strongly suggested 
that miR-146a-5p-enriched EVs, secreted from inflamma-
tory astrocytes or microglia, transfer their miR-146a-5p 
cargo to neurons.
To obtain definitive proof for glia-to-neuron shuttling 
of miRNAs via MVs we monitored neuronal levels of cel-
miR-39, a C. elegans miRNA, not expressed in rat cells, 
which cannot be upregulated in neurons upon contact with 
MVs. Neurons were transfected with a Renilla-based cel-
miR-39 reporter and incubated with MVs released from 
astrocytes exogenously expressing the miRNA. MVs 
released from cel-miR-39-transfected astrocytes efficiently 
transferred cel-miR-39 into neurons as indicated by reduced 
Renilla/firefly luciferase activity (Fig. 2j).
Vesicular miR‑146a‑5p regulates Syt1 and Nlg1 
protein expression in neurons
To investigate whether MVs transfer bioactive miR-
146a-5p to neurons, we first analysed immunoreactivity 
for Syt1, a validated miR-146a-5p target, in the soma and 
proximal dendrites of eGFP-transfected neurons. Astro-
cyte-derived MVs reduced by 50% Syt1 immunostain-
ing 48 h after MV administration to neurons, similarly 
to direct miR-146a-5p transfection, and the MV effect 
was rescued by transfection of donor glia with anti-miR-
146a-5p (Fig. 3a, b). The analysis was performed in the 
somatodendritic region because at this location Syt1 not 
incorporated into synapses is degraded at higher rate [19], 
and therefore early changes in Syt1 protein levels can be 
detected in this compartment. Accordingly, 48 h after MV 
addition, presynaptic terminals still displayed intense Syt1 
fluorescence (Fig. 3a, arrowhead) and no change of total 
Syt1 protein levels was detected by western blot analy-
sis (not shown). However, upon a longer treatment (72 h, 
with three MV additions, one every 24 h) MVs caused a 
significant decrease in expression of both Syt1 and Nlg1, 
another validated miR-146a-5p target (Fig. 3c). Inhibition 
of ATP-induced MV production by the purinergic antago-
nist oxidized-ATP (oATP) [7] prevented Nlg1 downreg-
ulation in receiving neurons (Fig. S4), confirming that 
ATP exacerbates the action of MVs. The impact of MVs-
associated miR-146a-5p on Syt1 and Nlg1 expression 
was further explored in neurons exposed to miR-146a-5p-
enriched or miR-146a-5p-depleted MVs derived from M1 
and M2 microglia (added freshly to neurons every 24 h 
for 72 h). As expected, MVs released from M1 microglia, 
but not MVs produced from M2 cells, decreased protein 
levels of Syt1 and Nlg1 (Fig. 3d). Prolonged exposure to 
inflammatory MVs did not alter the expression of genes 
not predicted to be targeted by miR-146a-5p (SNAP25, 
PSD95, and MAP2), indicating the absence of synaptic 
or neuronal damage (Fig. 3c, d). Analysis of cell viabil-
ity revealed similar percentage of calcein-positive and 
propidium iodide negative viable neurons in control and 
MVs-treated cultures (% of  calcein+/PI− neurons/overall 
nuclei: ctr = 69.32 ± 1.87; MVs = 81.83 ± 1.95; number 
of neurons: ctr = 355, MVs = 326; n = 3) further exclud-
ing neurotoxic effects.
Taken together, these data indicate that MVs secreted 
from inflammatory glial cells deliver bioactive miR-
146a-5p to neurons and modulate the expression of its 
synaptic targets according to their miR-146a-5p cargo.
Next we investigated whether transfer of miR-146a-5p 
via MVs might occur into neurons, when indirectly co-cul-
tured with inflammatory astrocytes or microglia (Fig. 3e), 
mimicking a more physiological condition. Western blot 
analysis showed a significant decrease in Nlg1 and Syt1 
in neurons maintained with either inflammatory microglia 
(at a 2:1 ratio) or astrocytes (at a 1:2 ratio) for 72 h com-
pared to neurons cultured alone (Fig. 3f). This suggests 
that reactive microglia and astrocytes deliver miR-146a-
5p-storing MVs to neurons in biologically relevant quanti-
ties. Of note, protein levels of SNAP25 were also reduced 
in neurons co-cultured with reactive astrocytes, revealing 
the possible contribution of other secretory molecules not 
associated to EVs to synaptic gene silencing. Moreover, 
protein levels of PSD95, a target gene of miR-125-5p, a 
miRNA upregulated in exosomes released from inflam-
matory microglia (Table 1), tended to decrease in neurons 
cultured with inflammatory microglia, suggesting a possi-
ble role for the exosome-associated miRNA in the control 
of synaptic genes.
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Inflammatory MVs affect synaptic stability via Nlg1 
downregulation
Nlg1 is a postsynaptic protein selectively expressed at 
excitatory synapses which is known to regulate spine for-
mation and synapse stability through binding to presynaptic 
neurexins [16, 70]. Thus, Nlg1 downregulation might affect 
dendritic spine and synapse density in neurons receiving 
inflammatory EVs. We tested this hypothesis in neurons 
transfected with RFP, to delineate dendritic spine morphol-
ogy. 72 h incubation with MVs derived from inflammatory 
astrocytes caused a significant decrease in spine density 
(Fig. 4a), mimicking the reduction induced by transfection 
with miR-146a-5p-GFP (Fig. 4b). To prove the involvement 
of Nlg1 downregulation in dendritic spine destabilization, 
we transfected neurons with a miR-146a-5p-resistant Nlg1, 
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lacking 3′-UTR sequence. Rescue of Nlg1 expression pre-
vented the decrease in spine density caused by inflammatory 
MVs (Fig. 4c).
Immunocytochemical staining for the presynaptic active 
zone marker Bassoon and the postsynaptic density marker 
Shank2 showed a significant decrease in the percentage of 
juxtaposed pre- and postsynaptic terminals (Fig. 4d) and in 
synaptic density (Fig. 4e) in neurons receiving inflamma-
tory MVs. Thus, loss of dendritic spines is accompanied by 
altered synaptic density.
MVs secreted from inflammatory 
but not pro‑regenerative microglia reduce spine 
and synaptic density
Dendritic spine destabilization in response to miR-146-en-
riched MVs was confirmed in neurons treated with MVs 
released from inflammatory microglia (M1-MVs), where 
loss of immature (thin) spines mostly accounted for reduced 
spine density (Fig. 4f). Similarly to MVs produced from 
reactive astrocytes, M1-MVs also decreased the frac-
tion (Fig. 4g) and density (Fig. 4h) of juxtaposed pre- and 
postsynaptic terminals. Conversely, MVs secreted from M2 
microglia, depleted in miR-146a-5p, did not cause spine loss 
and rather tended to increase the density of mature (mush-
room) spines (Fig. 4f). In addition, they had no effect on 
the fraction of juxtaposed pre- and postsynaptic terminals 
(Fig. 4g) and the density of synaptic contacts (Fig. 4h).
To evaluate the impact of inflammatory MVs on synap-
tic transmission, we analysed miniature excitatory postsyn-
aptic currents (mEPSCs) in 14-day-old neurons (Fig. 5a). 
Inflammatory MVs caused a significant decrease in mEPSC 
frequency (Fig. 5b) and amplitude (Fig. 5c), indicating a 
decrease in synaptic strength.
Chronic exposure to inflammatory EVs induces loss 
of dendritic spine in vivo
To validate our findings in vivo, M1-EVs derived from 
inflammatory rat microglia enriched in miR-146a-5p were 
administered to mice by chronic delivery (4 days) with pre-
filled Alzet mini-pumps, implanted into the CA1 region 
of the hippocampus. Quantitative analysis, performed on 
100-μm-thick brain sections stained by Golgi method, 
showed a decrease of ~ 30% in spine density compared to 
intact control, vehicle- and M2-EVs-injected mice (Fig. 6a, 
b). This result confirms in vivo that miR-146a-5p-enriched 
EVs released from inflammatory microglia promote den-
dritic spine loss, likely through downregulation of Nlg1, 
which is a validated miR-146a-5p target in both rat and 
mouse brain.
EVs fuse with neurons to deliver their miRNA cargo
Next we asked how MVs transfer their miRNA cargo to neu-
rons. EV–neuron interactions were analysed by delivering 
single MVs to neurons by optical tweezers and monitoring 
MV–neuron contact by time lapse microscopy [59]. After 
MV addition to neurons, MVs still suspended in the medium 
were trapped by the IR laser tweezers and positioned on neu-
ron cell bodies in spatially controlled manner. The trapping 
laser was switched off after 30 s to prove MV–cell interac-
tion (Fig. 7a). A large fraction of astrocyte-derived MVs 
adhered to the cell body of neurons (~ 74% n = 47) and 
more than half of microglial MVs was able to bind to neu-
ronal surface (~ 53% n = 30). Cloaking phosphatidyl-serine 
(PS) residues on MV surface with annexin-V decreased 
MV adhesion by 54% (number of ctr = 18, annexin-treated 
MVs = 15) proving that interaction of vesicular PS with cor-
responding neuronal receptor mediates contact of approxi-
mately half MVs (Fig. 7b, c). MV–neuron contact was also 
inhibited by 44% when neurons were treated with hepari-
tinase I, which cleaves HS chain of transmembrane pro-
teoglycans (syndecans) (number of ctr = 41, heparitinase-
treated neurons receiving MVs = 31) (Fig. 7d). This finding 
Fig. 3  Decreased Syt1 and Nlg1 expression in neurons exposed to 
miR-146a-5p-enriched MVs secreted from inflammatory glia. a Rep-
resentative pictures of Syt1 staining (red) in GFP-transfected neu-
rons maintained in resting conditions (ctr) or exposed to MVs from 
LPS-treated astrocytes for 48  h (48  h-MVs) and in miR-146a-5p-
GFP (BlockIt plasmid) transfected neurons. The structure of the cell 
body and proximal dendrites, where Syt1 fluorescence is measured, 
is revealed by eGFP. Arrows point to Syt1 staining in the cell bod-
ies while examples of Syt1 positive pre-synaptic puncta are high-
lighted by a white box and shown at higher magnification in the inset. 
Scale bar 10  μm. b The histogram shows quantitative analysis of 
Syt1 fluorescence in the somatodendritic region of GFP-transfected 
neurons (ctr), miR-146a-5p-GFP transfected neurons (miR), GFP-
transfected neurons exposed for 48  h to LPS-treated MVs (MVs) 
or from anti-miR-146a-5p-treated astrocytes (anti-miR). ANOVA 
Holm–Sidak multi-comparison test P  =  0.05; number of neurons: 
ctr = 20, miR = 15, MVs = 20, anti-miR = 16, n = 3. c WB analysis 
of hippocampal neurons showing downregulation of Syt1 and Nlg1 
but not MAP2, SNAP25 and PDS95 after 72 h treatment with MVs 
secreted from LPS-treated astrocytes. GAPDH is used as loading 
control. Unpaired Student’s t test: Syt1 P = 0.008, Nlg1 P = 0.001, 
MAP2 P = 0.342, SNAP25 P = 0.343, PSD95 P = 0.519; n = 3. d 
WB analysis of Syt1, Nlg1 SNAP25 and PSD95 in control neurons 
and neurons exposed to miR146-enriched MVs derived from inflam-
matory microglia (M1-MVs) or miR-146 depleted MVs derived from 
pro-regenerative microglia (M2-MVs) for 72  h. One-way ANOVA, 
Dunn’s method comparison test: Syt1 P  <  0.05, Nlg1 P  <  0.05, 
SNAP25 P = 0.676, PSD95 P = 0.2; n = 3. e Schematic represen-
tation neurons indirectly co-cultured with inflammatory astrocytes or 
microglia. f WB analysis of Syt1, Nlg1, NR2B and PSD95 in control 
neurons and neurons indirectly co-cultured with LPS-treated astro-
cytes or inflammatory microglia for 72  h. Unpaired Student’s t test 
for astrocyte coculture: Syt1 P  <  0.001, Nlg1 P  =  0.003, SNAP25 
P  =  0.011, PSD95 P  =  1.000; n  =  3 and Unpaired Student’s t test 
for microglia coculture: Syt1 P  =  0.05, Nlg1 P  =  0.007, SNAP25 
P = 0.690, PSD95 P = 0.097; n = 3
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revealed that neuronal syndecans contribute via their HS 
chain to MV adhesion. After contact with neuron cell bod-
ies, MVs showed little displacements around the place of 
delivery and remained attached to the neuron surface for 
up to 1–2 h of recording (Fig. 7b). Importantly, none of 
the MVs attached to neurons disappeared from the observa-
tion field, thus excluding rapid MV uptake or full fusion 
with the neuron plasma membrane (PM). Based on these 
findings we next investigated whether EV–neuron contact 
may be accompanied by transient fusion of the MVs with 
the PM. By spinning disk confocal microscopy we imaged 
the contact between neurons and MVs, pre-loaded with 
calcein, a fluorescent probe (green) that gets trapped in the 
MV lumen [1] and with self-quenching concentrations of the 
lipophilic membrane dye R18 (red) [48] (Fig. 7e). Briefly, 
double-stained MVs were added to neuronal medium and 
their movement by gravity towards neurons in the micro-
scope field was tracked using green calcein fluorescence. 
When single MVs approached the neuron membrane, cal-
cein (green) and R18 (red) fluorescence images were col-
lected at 2 scan/s along with bright field to track dynamics of 
MV–neuron interaction. An example of MV approaching to 
the surface of a neurite is shown in Fig. 7f, g. Temporal plot 
of R18 fluorescence intensity revealed increases in R18 sig-
nal at the site of contacts (Fig. 7h, i), indicating dequenching 
of the dye upon fusion and dilution into the neuron PM. R18 
dequenching was not accompanied by a decrease in calcein 
fluorescence, suggesting that fusion between MVs and neu-
rons led to the opening of a transient pore, non-permeable 
to calcein.
Discussion
Our study reveals a previously unrecognized mechanism 
behind loss of excitatory synapses during brain inflamma-
tion. We show that miR-146a-5p, which represses translation 
of presynaptic Syt1 and postsynaptic Nlg1, is upregulated 
in EVs secreted from reactive microglia either exposed to 
inflammatory or degenerative stimuli, and is delivered to 
neurons upon EV fusion with the plasma membrane. Nota-
bly, protein levels of Syt1 and Nlg1 are decreased, the den-
sity of dendritic spines and excitatory synapses is reduced, 
and spontaneous miniature synaptic currents are dimin-
ished in receiving neurons, indicating important synaptic 
alterations.
Our previous studies have shown that microglia-derived 
MVs affect the presynaptic compartment causing an excita-
tion–inhibition unbalance. MVs acutely enhance glutamate 
release while suppress spontaneous GABA transmission 
in both hippocampal cultures [62] and in the visual cor-
tex [1] and their action is due to the lipid components of 
MVs. This has been clearly proved at GABAergic termi-
nals, where MVs-associated endocannabinoids stimulate 
cannabinoid receptor type 1 (CB1) and rapidly decrease 
spontaneous GABA release [29]. Importantly, presynaptic 
changes caused by microglial MVs are independent of the 
phenotype of donor microglia (unstimulated, pro-inflamma-
tory or pro-regenerative cells) [1], suggesting that bioactive 
lipids secreted in association with MVs may contribute to 
homeostatic regulation of neurotransmission, in the absence 
of inflammation and microglia reaction.
In this study, we have identified miRNAs as additional 
active components of inflammatory MVs that are respon-
sible for a delayed destabilization of excitatory synapses 
Fig. 4  Decreased density of dendritic spines and synapses in neurons 
exposed to MVs secreted from inflammatory astrocytes and micro-
glia. a Analysis of spine density in 17-day-old RFP-positive neurons 
(ctr), and neurons exposed for 72 h to MVs derived from LPS-treated 
astrocytes (MVs). Unpaired Student’s t test P  ≤  0.001; number of 
neurons: ctr = 70, MVs = 71, n = 3. Scale bar 5 μm. b Analysis of 
spine density in control GFP-transfected neurons (ctr) and miR-146a-
5p-GFP transfected neurons (miR). Mann–Whitney rank sum test: 
P  =  0.013; number of neurons: ctr  =  42, MVs  =  42, n  =  3. Scale 
bar 5 μm. c Representative fluorescence pictures of RFP-positive neu-
rons, co-transfected with hemagglutinin (HA)-tagged Nlg1 (green) 
or mock-transfected, maintained in control conditions or exposed to 
MVs from LPS-treated astrocytes. The histograms show correspond-
ing dendritic spine density. ANOVA, Tukey multiple comparison 
test: P ≤ 0.001; number of neurons: ctr = 26, MVs = 27, Nlg1 = 28, 
NLG1 + MVs = 24, n = 3. Scale bar 5 μm. d Staining for the pre-
synaptic marker Bassoon (red), and the postsynaptic protein Shank2 
(green) in control neurons and neurons treated with astrocytic MVs. 
The histograms show the percentage of juxtaposed pre- and post-
synaptic terminals (Bassoon & Shank2 co-localizing puncta) rela-
tive to the total post-synaptic puncta (Shank2 puncta). Unpaired 
Student’s t test: P  ≤  0.001; number of fields: ctr  =  78, MVs  =  82, 
n = 3. Scale bar 2 μm. e Control and MVs-treated RFP-positive neu-
rons (red) stained for Bassoon (blue) and Shank2 (green). Histograms 
show corresponding density of synaptic contacts. Unpaired Student’s 
t test: P  =  0.028; number of neurons: ctr  =  22, MVs  =  22, n  =  3. 
Scale bar: 2 μm. f Analysis of total spine density in untreated RFP-
positive neurons (ctr) or cells incubated with MVs derived from 
inflammatory (M1-MVs) or pro-regenerative (M2-MVs) microglia. 
ANOVA, Tukey multiple comparison test: P ≤ 0.05, number of neu-
rons for total spine density: ctr = 62, M1-MVs = 60, M2-MVs = 62; 
P = 0.293, number of neurons for mushroom spine density: ctr = 62, 
M1-MVs = 60, M2-MVs = 62; P ≤ 0.05, number of neurons for thin 
spine density: ctr = 62, M1-MVs = 60, M2-MVs = 62; P = 0.069, 
number of neurons for stubby spine density: ctr = 62, M1-MVs = 60, 
M2-MVs  =  62; n  =  3. Scale bar 4  μm. The decrease in the num-
ber of total protrusions in M1-MVs-treated neurons is mostly due 
to a decrease in immature thin spines. g Staining for Bassoon (red) 
and Shank2 (green) in control neurons and neurons treated with 
M1-MVs or M2-MVs. The histograms show the percentage of Bas-
soon and Shank2 co-localizing puncta relative to postsynaptic 
puncta. ANOVA, Tukey Multiple comparison test: P ≤ 0.05, number 
of fields: ctr = 33, M1-MVs = 33, M2-MVs = 33; n = 3. Scale bar 
2 μm. h RFP-positive neurons stained for Bassoon (blue) and Shank2 
(green) under resting condition or after incubation with M1-MVs or 
M2-MVs. Histograms show corresponding density of synaptic con-
tacts. ANOVA, Tukey Multiple comparison test: P  ≤  0.05, number 
of neurons: ctr = 48, M1-MVs = 48, M2-MVs = 40; n = 3. Scale bar 
2 μm
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and decreased transmission, which selectively occur during 
chronic inflammation.
EVs transfer their miRNA cargo to neurons
We have provided formal proof for EV-mediated shuttling of 
miRNAs between reactive glia and neurons and consequent 
downregulation of their synaptic targets in a number of 
ways: (1) monitoring neuronal levels of cel-miR-39, a C. ele-
gans miRNA not present in rat neurons, with a Renilla-based 
specific reporter indicated that MVs exogenously expressing 
the cel-miR-39, secreted from cel-miR-39 transfected astro-
cytes, deliver their miRNA cargo to the cytoplasm of neu-
rons; (2) monitoring miR-146a-5p, a glia-specific miRNA 
upregulated in EVs produced by inflammatory glia, showed 
that miR-146a-5p levels increase in neurons transfected with 
a specific Renilla reporter in response to inflammatory EVs 
but not EVs released from anti-miR-146a-5p-treated cells; 
(3) glia-to-neuron transfer of miR-146a-5p did not occur 
when EV–neuron contact was prevented by cloaking vesicu-
lar PS, a key signal for EV recognition on neurons.
MVs‑associated miR‑146a‑5p causes synaptic 
alterations through Nlg1 downregulation
The main accomplishment of our study is the demonstra-
tion that exchange of miR-146a-5p (and possibly other miR-
NAs) between inflammatory microglia and neurons via EVs 
causes important alterations of synaptic structure and func-
tion, independent of neuronal damage.
We have shown that transfer of miR-146a-5p via EVs is 
sufficient to decrease Syt1 and Nlg1 expression, to reduce 
dendritic spine in vitro and in the CA1 region of the hip-
pocampus and to decrease synapse density and strength in 
Fig. 5  Inflammatory MVs decrease frequency and amplitude of 
mEPSCs. a Representative traces of mEPSCs from control and MVs-
treated hippocampal cultures. b Summary histogram showing the 
mean frequency of mEPSCs from control and MVs-treated neurons 
(P  =  0.024 Mann–Whitney rank sum test) c. Summary histogram 
showing the mean amplitudes of mEPSCs from control and MVs-
treated neurons (number of cells: ctr  =  33, MVs  =  31; P  =  0.036 
Mann–Whitney rank sum test)
Fig. 6  Exposure to M1-EVs, but not M2-EVs, reduces spine density 
in CA1 neurons. a Representative pictures of secondary dendrites 
of CA1 neurons in intact mice (contralateral hippocampus), vehicle-
injected mice or upon treatment with either M2- or M1-EVs derived 
from rat microglia. b Quantification of spine densities. ANOVA, 
Bonferroni multiple comparison test, main effect of treatment: 
P = 0.0004; total length analysed: 2778 μm intact, 2694 μm vehicle, 
3124 μm M2-EVs, 2794 μm M1-EVs, 90 dendrites for group, n = 3 
mice. Scale bar 5 μm
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cultured neurons, revealing that this miRNA hampers proper 
synapse stability and function. This evidence arose from sev-
eral observations: (1) reduced Syt1 and Nlg1 expression in 
neurons incubated with miR146a-enriched MVs (derived 
from inflammatory microglia or astrocytes), but not miR-
146a-5p-depleted MVs (released from pro-regenerative 
microglia) or MVs storing inactive miR-146a-5p (produced 
by astrocytes treated with a miR-146a-5p inhibitor); (2) 
reduced spine and synapse density in neurons exposed to 
miR146a-enriched MVs, derived from either reactive micro-
glia or astrocytes, not occurring when neurons were exposed 
to miR146a-depleted MVs, derived from IL4-treated micro-
glia; (3) decreased Syt1 immunoreactivity and decreased 
spine density in neurons transfected with miR-146a-5p. We 
also demonstrated that miR-146a-5p shuttling destabilizes 
dendritic spines via Nlg1 downregulation, as indicated by 
rescue of dendritic spine density in neurons expressing a 
miR-146-insensitive Nlg1, treated with inflammatory MVs.
Other miRNAs targeting synaptic genes are enriched in 
MVs produced by inflammatory microglia. Among them, 
miR-223, which targets the AMPA-selective glutamate 
receptor 2 (GluR2) and the NMDA glutamate receptor 
gluN2B [33] and miR-181a which regulates only gluN2B 
[66], a receptor essential to form LTP [8, 71]. We did not 
find significant changes in gluN2B protein expression in 
neurons co-cultured with inflammatory glial cells. How-
ever, the decreased amplitude of AMPA-mediated mEPSC 
suggests that miR-223 may indeed be involved in altera-
tion of spontaneous excitatory transmission in MVs-treated 
neurons. Additional experiments are necessary to clarify 
whether MVs-associated miR-223 may alter GluR2 expres-
sion in neurons and whether synaptic dysfunctions may 
result from the combined action of multiple miRNAs.
Previous work has linked changes in miRNA expression 
and EV production to synaptic plasticity. Neuron depolari-
zation has been shown to induce release of EVs containing 
high amounts of miRNAs, and miRNA elimination has been 
proposed to promote rapid translation of proteins required 
for synaptic plasticity [31]. Our study extends and comple-
ments these findings by showing that glia-to-neuron transfer 
of miR-146a-5p suppresses translation of a key dendritic 
protein, Nlg1, and decreases synaptic density and strength. 
These synaptic changes may represent a compensatory 
response to preserve neuronal circuit, and counteract acute 
hyperexcitability and excessive glutamatergic transmis-
sion, caused by inflammatory cytokines released by reac-
tive glia. Consistent with the idea of a rescue mechanism, 
miR-146a-5p has well known immunosuppressive and anti-
inflammatory functions [20, 35, 76]. Its silencing activity 
has recently been shown to decrease hyperexcitability-
underlying seizures in a model of epileptogenesis, where 
gliosis and inflammatory cytokines are major pathogenic 
factors [34]. However, in this study we show that sustained 
exposure of neurons to miR-146a-5p-enriched MVs causes 
over-inhibition of synaptic function and excessive synapse 
destabilization, leading to pathological loss of synapses, not 
linked to neuron damage, which may underlie synaptic dys-
function occurring in chronic inflammation.
EVs‑mediated shuttling of miRNAs from microglia 
to neurons: possible mechanism at the bases 
of cognitive symptoms?
The enrichment of miRNAs targeting dendritic genes in EVs 
secreted from microglia under both inflammatory and neuro-
degenerative conditions suggests that these miRNAs maybe 
linked to common alteration of synaptic functions occurring 
in both inflammatory and degenerative contexts. Consist-
ently, miR-146a-5p, miR-181a and miR-223 have been pre-
viously shown to be dysregulated in the CNS, plasma, and/
or immune cells of MS patients [36] but also implicated in 
neurodegenerative diseases [22, 32, 37, 61].
Multiple sclerosis (MS) is a synaptic disorder charac-
terized by chronic microglia activation and enhanced EV 
secretion [78] with early onset compared to other neurode-
generative diseases. Despite a quarter of MS patients suf-
fer symptoms arising from neuronal dysfunction, such as 
episodic memory impairment, already at the first clinical 
episode and show hippocampal microstructural damage [57, 
63] we still lack a full understanding of how synaptic altera-
tions start and how they are linked to microglia activation. 
Here we show that miR-146a-5p, together with miR-181a 
and miR-223 are present in EVs isolated from the CSF of 
a group of MS patients. This evidence provides a possible 
link between microglia activation, enhanced EV produc-
tion and cognitive symptoms in MS patients. Despite not 
attracting interest as specific MS biomarkers, we anticipate 
that analysis of miRNA expression in myeloid EVs isolated 
from CSF or plasma of single subjects might clarify whether 
miR-146a-5p, miR-223 and/or miR-181a content has power 
to reflect or predict the development of cognitive symptoms 
in MS as well as in other neuroinflammatory disorders. 
Besides being useful biomarkers of cognitive dysfunction, 
these miRNAs may also represent therapeutic targets for the 
improvement of cognitive symptoms in brain inflammatory 
diseases.
Inflammatory MVs deliver their cargo to neurons 
through transient fusion with the PM
Despite recent advances in EV research, how RNA content 
of EVs is delivered to target cells and whether all EVs are 
capable to deliver their cargo is still largely unclear [75]. 
Using optical tweezers, a unique tool to finely position 
single EVs on target cells and to study EV-cell interaction 
individually [59], here we show that a relevant fraction of 
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MVs derived from microglia or astrocytes adhere to neu-
rons, and can therefore be potentially functional as com-
munication vehicles. MVs are heterogeneous with respect 
to their adhesive properties. The exposure of PS, a known 
recognition signal for receiving cells [50], mediates bind-
ing of about half glial MVs to neurons. Similarly, heparan 
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sulfate proteoglycans [14] on the surface of receiving neu-
rons mediate the interaction with only a fraction of MVs, 
indicating that multiple molecules are likely to participate 
in MV–neuron contact.
Further work remains to be done to define the minimum 
number of inflammatory EVs required to alter miR-146a-5p 
levels in neurons and to suppress its target genes, a chal-
lenging goal that goes beyond the aim of the present study. 
Nevertheless, co-cultures experiments suggest that reactive 
glia deliver miR-146a-5p to neurons via MVs in biological 
relevant quantities. Indeed, both Syt1 and Nlg1 are signifi-
cantly downregulated in neurons indirectly co-cultured with 
inflammatory microglia at a physiological ratio.
A prominent finding of our study is that glial EVs deliver 
their cargo to neurons by transient fusion. This is revealed 
by dynamic imaging of EVs stained within the lumen with 
calcein and in the membrane with the self-quenching lipo-
philic dye R18 [48]. MV fusion was proven by dequenching 
of R18 fluorescence at contact sites while calcein retention 
in MVs suggested the opening of small pores, not perme-
able to the cytosolic dye. To our knowledge, these data are 
the first direct evidence that glia-derived EVs fuse with 
the neuron plasma membrane. Importantly, EV fusion also 
occurs along neuronal processes, where synaptic activity is 
influenced by EVs [1, 62]. EV fusion allows direct retrieval 
of EV cargo in the cytosol of neurons, avoiding degradation 
in late endosome or lysosomes, where EVs may accumulate 
after endocytosis [13, 26, 28]. Such a mechanism would also 
overcome the issue of how miRNAs might be retrieved back 
from endocytic compartments. Fusion of EVs with the neu-
ron membrane is consistent with previous studies showing 
that EVs of microglia and neuron origin efficiently bind to 
the cell surface of neurons but are only rarely [13], if ever 
[29], internalized.
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